Selected research
Industry Research
Biolayer Interferometry (BLI) Industry Research Report 2026
Market perspective
The global Biolayer Interferometry (BLI) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biolayer Interferometry (BLI) market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biolayer Interferometry (BLI) market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biolayer Interferometry (BLI) market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biolayer Interferometry (BLI) include Ichor Life Sciences, Inc, Creative BioMart, GenScript, ROCKLAND IMMUNOCHEMICALS, INC, BPS Bioscience, Inc, Creative Proteomics, Creative Biostructure, Profacgen and Creative Biolabs, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biolayer Interferometry (BLI) market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biolayer Interferometry (BLI).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biolayer Interferometry (BLI) Market by Company
Ichor Life Sciences, Inc
Creative BioMart
GenScript
ROCKLAND IMMUNOCHEMICALS, INC
BPS Bioscience, Inc
Creative Proteomics
Creative Biostructure
Profacgen
Creative Biolabs
Biocult
KMD Bioscience Co., Ltd
Biolayer Interferometry (BLI) Segment by Type
Affinity and Kinetic Analysis
Drug and Antibody Screening
Drug and Antibody Discovery
Protein Quantification
Others
Biolayer Interferometry (BLI) Segment by Application
Pharmaceutical Industry
Diagnostics
Biotechnology
Scientific Research
Others
Biolayer Interferometry (BLI) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biolayer Interferometry (BLI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biolayer Interferometry (BLI) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biolayer Interferometry (BLI).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biolayer Interferometry (BLI) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Affinity and Kinetic Analysis
- Drug and Antibody Screening
- Drug and Antibody Discovery
- Protein Quantification
- Others
Applications
- Pharmaceutical Industry
- Diagnostics
- Biotechnology
- Scientific Research
- Others
Companies covered
- Ichor Life Sciences, Inc
- Creative BioMart
- GenScript
- ROCKLAND IMMUNOCHEMICALS, INC
- BPS Bioscience, Inc
- Creative Proteomics
- Creative Biostructure
- Profacgen
- Creative Biolabs
- Biocult
- KMD Bioscience Co., Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biolayer Interferometry (BLI) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Affinity and Kinetic Analysis
- 2.2.3 Drug and Antibody Screening
- 2.2.4 Drug and Antibody Discovery
- 2.2.5 Protein Quantification
- 2.2.6 Others
- 2.3 Biolayer Interferometry (BLI) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Diagnostics
- 2.3.4 Biotechnology
- 2.3.5 Scientific Research
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Biolayer Interferometry (BLI) Breakdown Data by Type
- 3.1 Global Biolayer Interferometry (BLI) Historic Market Size by Type (2021-2026)
- 3.2 Global Biolayer Interferometry (BLI) Forecasted Market Size by Type (2027-2032)
4 Biolayer Interferometry (BLI) Breakdown Data by Application
- 4.1 Global Biolayer Interferometry (BLI) Historic Market Size by Application (2021-2026)
- 4.2 Global Biolayer Interferometry (BLI) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biolayer Interferometry (BLI) Market Perspective (2021-2032)
- 5.2 Global Biolayer Interferometry (BLI) Growth Trends by Region
- 5.2.1 Global Biolayer Interferometry (BLI) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biolayer Interferometry (BLI) Historic Market Size by Region (2021-2026)
- 5.2.3 Biolayer Interferometry (BLI) Forecasted Market Size by Region (2027-2032)
- 5.3 Biolayer Interferometry (BLI) Market Dynamics
- 5.3.1 Biolayer Interferometry (BLI) Industry Trends
- 5.3.2 Biolayer Interferometry (BLI) Market Drivers
- 5.3.3 Biolayer Interferometry (BLI) Market Challenges
- 5.3.4 Biolayer Interferometry (BLI) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biolayer Interferometry (BLI) Players by Revenue
- 6.1.1 Global Top Biolayer Interferometry (BLI) Players by Revenue (2021-2026)
- 6.1.2 Global Biolayer Interferometry (BLI) Revenue Market Share by Players (2021-2026)
- 6.2 Global Biolayer Interferometry (BLI) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biolayer Interferometry (BLI) Head Office and Area Served
- 6.4 Global Biolayer Interferometry (BLI) Players, Product Type & Application
- 6.5 Global Biolayer Interferometry (BLI) Manufacturers Established Date
- 6.6 Global Biolayer Interferometry (BLI) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biolayer Interferometry (BLI) Market Size (2021-2032)
- 7.2 North America Biolayer Interferometry (BLI) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
- 7.4 North America Biolayer Interferometry (BLI) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biolayer Interferometry (BLI) Market Size (2021-2032)
- 8.2 Europe Biolayer Interferometry (BLI) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
- 8.4 Europe Biolayer Interferometry (BLI) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biolayer Interferometry (BLI) Market Size (2021-2032)
- 9.2 Asia-Pacific Biolayer Interferometry (BLI) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biolayer Interferometry (BLI) Market Size (2021-2032)
- 10.2 South America Biolayer Interferometry (BLI) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
- 10.4 South America Biolayer Interferometry (BLI) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biolayer Interferometry (BLI) Market Size (2021-2032)
- 11.2 Middle East & Africa Biolayer Interferometry (BLI) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Ichor Life Sciences, Inc
- 12.1.1 Ichor Life Sciences, Inc Company Information
- 12.1.2 Ichor Life Sciences, Inc Business Overview
- 12.1.3 Ichor Life Sciences, Inc Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.1.4 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product Portfolio
- 12.1.5 Ichor Life Sciences, Inc Recent Developments
- 12.2 Creative BioMart
- 12.2.1 Creative BioMart Company Information
- 12.2.2 Creative BioMart Business Overview
- 12.2.3 Creative BioMart Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.2.4 Creative BioMart Biolayer Interferometry (BLI) Product Portfolio
- 12.2.5 Creative BioMart Recent Developments
- 12.3 GenScript
- 12.3.1 GenScript Company Information
- 12.3.2 GenScript Business Overview
- 12.3.3 GenScript Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.3.4 GenScript Biolayer Interferometry (BLI) Product Portfolio
- 12.3.5 GenScript Recent Developments
- 12.4 ROCKLAND IMMUNOCHEMICALS, INC
- 12.4.1 ROCKLAND IMMUNOCHEMICALS, INC Company Information
- 12.4.2 ROCKLAND IMMUNOCHEMICALS, INC Business Overview
- 12.4.3 ROCKLAND IMMUNOCHEMICALS, INC Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.4.4 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product Portfolio
- 12.4.5 ROCKLAND IMMUNOCHEMICALS, INC Recent Developments
- 12.5 BPS Bioscience, Inc
- 12.5.1 BPS Bioscience, Inc Company Information
- 12.5.2 BPS Bioscience, Inc Business Overview
- 12.5.3 BPS Bioscience, Inc Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.5.4 BPS Bioscience, Inc Biolayer Interferometry (BLI) Product Portfolio
- 12.5.5 BPS Bioscience, Inc Recent Developments
- 12.6 Creative Proteomics
- 12.6.1 Creative Proteomics Company Information
- 12.6.2 Creative Proteomics Business Overview
- 12.6.3 Creative Proteomics Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.6.4 Creative Proteomics Biolayer Interferometry (BLI) Product Portfolio
- 12.6.5 Creative Proteomics Recent Developments
- 12.7 Creative Biostructure
- 12.7.1 Creative Biostructure Company Information
- 12.7.2 Creative Biostructure Business Overview
- 12.7.3 Creative Biostructure Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.7.4 Creative Biostructure Biolayer Interferometry (BLI) Product Portfolio
- 12.7.5 Creative Biostructure Recent Developments
- 12.8 Profacgen
- 12.8.1 Profacgen Company Information
- 12.8.2 Profacgen Business Overview
- 12.8.3 Profacgen Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.8.4 Profacgen Biolayer Interferometry (BLI) Product Portfolio
- 12.8.5 Profacgen Recent Developments
- 12.9 Creative Biolabs
- 12.9.1 Creative Biolabs Company Information
- 12.9.2 Creative Biolabs Business Overview
- 12.9.3 Creative Biolabs Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.9.4 Creative Biolabs Biolayer Interferometry (BLI) Product Portfolio
- 12.9.5 Creative Biolabs Recent Developments
- 12.10 Biocult
- 12.10.1 Biocult Company Information
- 12.10.2 Biocult Business Overview
- 12.10.3 Biocult Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.10.4 Biocult Biolayer Interferometry (BLI) Product Portfolio
- 12.10.5 Biocult Recent Developments
- 12.11 KMD Bioscience Co., Ltd
- 12.11.1 KMD Bioscience Co., Ltd Company Information
- 12.11.2 KMD Bioscience Co., Ltd Business Overview
- 12.11.3 KMD Bioscience Co., Ltd Revenue in Biolayer Interferometry (BLI) Business (2021-2026)
- 12.11.4 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product Portfolio
- 12.11.5 KMD Bioscience Co., Ltd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst